WallStreetZenWallStreetZen

NASDAQ: UPC
Universe Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

UPC past revenue growth

How has UPC's revenue growth performed historically?
Company
-19.52%
Industry
10.18%
Market
17.2%
UPC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
UPC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

UPC earnings and revenue history

Current Revenue
$32.3M
Current Earnings
-$6.2M
Current Profit Margin
-19.1%

UPC Return on Equity

Current Company
-14.3%
Current Industry
10.7%
Current Market
-8.4%
UPC's Return on Equity (-14.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when UPC announces earnings.

UPC Return on Assets

Current Company
-10.9%
Current Industry
2.9%
UPC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

UPC Return on Capital Employed

Current Company
-9.34%
Current Industry
5.5%
UPC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UPC vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
UPC$32.31M-$3.18M-$6.16M-0.70%N/A
BFRI$34.07M-$18.59M-$20.13M+6.81%N/A
COSM$49.59M-$12.79M-$42.91M+4.62%N/A
CLVR$17.42M-$14.94M-$17.90M+22.11%N/A
SHPH$0.00-$4.09M-$6.59MN/AN/A
View Top Pharmaceutical Stocks

Universe Pharmaceuticals Earnings & Revenue FAQ

What were UPC's earnings last quarter?

Universe Pharmaceuticals (NASDAQ: UPC) reported Q3 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Universe Pharmaceuticals earnings for the quarter were N/A. In the same quarter last year, Universe Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Universe Pharmaceuticals stock.

What was UPC's earnings growth in the past year?

As of Q2 2024, Universe Pharmaceuticals's earnings has grown year over year. Universe Pharmaceuticals's earnings in the past year totalled -$6.16 million.

What was UPC's revenue last quarter?

Universe Pharmaceuticals (NASDAQ: UPC) reported Q3 2023 revenue of N/A up N/A year over year. In the same quarter last year, Universe Pharmaceuticals's revenue was N/A.

What was UPC's revenue growth in the past year?

As of Q2 2024, Universe Pharmaceuticals's revenue has grown -19.52% year over year. This is 29.7 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Universe Pharmaceuticals's revenue in the past year totalled $32.31 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.